Medication info
Borirabe 20 mg (Rabeprazole Sodium)

Borirabe 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Kyungjin Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablets
Packaging
28 tablets (14 tablets/ PTP packaging × 2)
Approval status
Active

MFDS item code 201603749 · Approved 2016.06.22 · Insurance code 660402640

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If treatment is not successful after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of 10 mg or 20 mg twice daily may be administered orally. However, 20 mg twice daily should be limited to patients with confirmed severe mucosal damage. Symptom relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled with on-demand therapy using 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended that this medicine 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be given in 2 divided doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Since hepatic function is often impaired, administer with caution.
Child dose
Safety in pediatric patients has not been established.

Ingredients

Manufacturer
Kyungjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of ulcers that develop in the stomach and duodenum. It alleviates the symptoms of gastroesophageal reflux disease and prevents recurrence through long-term treatment. For patients with gastrointestinal ulcers caused by Helicobacter pylori infection, it is used in combination with antibiotics to enhance treatment efficacy. It is also effective for conditions such as Zollinger-Ellison syndrome, which involves excessive gastric acid secretion. This medication is used for the treatment and symptom improvement of various gastrointestinal diseases.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If treatment is not successful after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of 10 mg or 20 mg twice daily may be administered orally. However, 20 mg twice daily should be limited to patients with confirmed severe mucosal damage. Symptom relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled with on-demand therapy using 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended that this medicine 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be given in 2 divided doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Since hepatic function is often impaired, administer with caution.

Child dose

Safety in pediatric patients has not been established.

Precautions

This medication should not be used in patients with specific allergic reactions or who are hypersensitive to certain antibiotics. Pregnant or breastfeeding women should not take this medication. Patients with impaired liver function or elderly patients should exercise greater caution when taking this medication. This medication may cause allergic symptoms such as skin rash and itching, so if these symptoms occur, it should be discontinued immediately. Blood tests and liver function tests should be performed regularly, and if abnormal symptoms are found, a consultation with a doctor is necessary. Various side effects may occur, including those affecting the heart, gastrointestinal system, and nervous system, so any symptoms should be reported immediately. There is an increased risk of fractures with long-term use, so the duration of use should follow the doctor's instructions. Interactions with certain medications may occur while taking this medication, so inform healthcare professionals when taking other medications. Caution is required as drowsiness may occur when driving or operating machinery. Keep out of reach of children and swallow tablets whole without chewing or crushing them. The risk of gastrointestinal infections may slightly increase, so if diarrhea persists, consult a healthcare professional. Pregnant or breastfeeding women should not use this medication as safety has not been confirmed. Long-term use may affect vitamin B12 absorption, so regular check-ups are necessary. If any abnormal symptoms appear on the skin or throughout the body while taking this medication, it should be discontinued immediately and a specialist consulted.

Side effects

Rash, hives, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distention, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbance, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenosis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb flaccidity, decreased perception, decreased grip strength, language confusion, staggering, delirium, spatial disorientation, drowsiness, cough, pharyngitis, rhinitis, dyspnea, asthma, nosebleed, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blur, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, increased urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, discoid lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air and moisture. It is safe to store between 1 to 30 degrees Celsius at room temperature. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablets

Package unit

28 tablets (14 tablets/ PTP packaging × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.